OriCell Therapeutics (原启生物科技（上海）有限责任公司) is a biotech company specializing in tumor immunotherapy drug development. Its long-term development strategy is to focus on the clinical needs for the treatment of liver cancer, ovarian cancer, gastric cancer, cervical cancer, and non-small cell lung cancer, and develop cellular drugs and bispecific antibodies with high clinical values.